Sentences with phrase «of neck cancer»

These kinds of sensors could also track the recovery of neck cancer patients, who commonly develop swallowing and speaking problems caused by radiation therapy and surgery, Rogers says.

Not exact matches

The procedure was done in the neck of a 12 - year - old boy who had developed cancer.

Dimon, who is the longest - serving CEO of the major banks, said that he had undergone tests including a CAT scan, PET scan and a biopsy, which showed that the cancer is confined to the throat and the adjacent lymph nodes on the right side of his neck.

Extreme (but plausible) results of sitting for extended periods of time include: heart disease, overproductive pancreas, colon cancer, foggy brain, strained neck, sore shoulders and back, mushy abs, tight hips, limp glutes, inflexible spine, disc damage, poor circulation, and soft bones.

Cancer - free following his latest quarterly checkup, ex-Buffalo Bills Hall - of - Fame quarterback Jim Kelly is drawing on his experiences to aid others battling head and neck cancer, teaming up with several cancer organizations and pharmaceutical giant Merck to produce a promotional campaign titled «Your Cancer Game Plan,» which debuted Cancer - free following his latest quarterly checkup, ex-Buffalo Bills Hall - of - Fame quarterback Jim Kelly is drawing on his experiences to aid others battling head and neck cancer, teaming up with several cancer organizations and pharmaceutical giant Merck to produce a promotional campaign titled «Your Cancer Game Plan,» which debuted cancer, teaming up with several cancer organizations and pharmaceutical giant Merck to produce a promotional campaign titled «Your Cancer Game Plan,» which debuted cancer organizations and pharmaceutical giant Merck to produce a promotional campaign titled «Your Cancer Game Plan,» which debuted Cancer Game Plan,» which debuted today.

Epstein - Barr is best known for causing infectious mononucleosis, but it is also associated with an increased risk for several cancers, as well as a rare type of head and neck cancer called nasopharyngeal carcinoma.

She and other colleagues first noticed an odd shift in patient profiles in the late 1990s: younger men were showing up in her clinic, often with no significant history of smoking or heavy drinking, which are risk factors for head and neck cancers.

Previous studies by the University of South Carolina's Lucia Pirisi - Kim Creek research group had reported the existence of an HPV - inactive class in head and neck cancers and raised the possibility that HPV - inactive cervical cancers might originate as virally driven cancers and subsequently act independent of HPV.

Even though this is a relatively rare cancer, we know HPV is important in a number of other tumors, including those of the head and neck.

The study, was reported Feb 13 to the 5th International Conference on Innovative Approaches in Head and Neck Oncology (ICHNO) will reduce significantly the number of HNSCC patients who currently undergo selective neck dissection (SND), a procedure which involves removing a group of lymph nodes from the neck in order to try to eradicate those which may have been reached by the cancer.

A new tracer can enable surgeons to make an accurate identification of the sentinel node — the lymph node to which cancer spreads first — and hence spare patients the post-operative complications that may be linked to the removal of a group of lymph nodes in the neck.

Immunotherapy doubles overall survival and improves quality of life, with fewer side effects, in a treatment - resistant and rapidly progressing form of head and neck carcinoma, reports a large, randomized international trial co-led by investigators at the University of Pittsburgh Cancer Institute (UPCI).

«These exciting results indicate that there is a new standard of care option for a population of head and neck cancer patients with no other treatment options,» said the trial's international co-chair Robert Ferris, M.D., Ph.D., UPMC Endowed Professor, and chief of the Division of Head and Neck Surgery and co-leader of the Cancer Immunology Program atcancer patients with no other treatment options,» said the trial's international co-chair Robert Ferris, M.D., Ph.D., UPMC Endowed Professor, and chief of the Division of Head and Neck Surgery and co-leader of the Cancer Immunology Program atCancer Immunology Program at UPCI.

Although Merck's vaccine will be marketed only for cervical cancer, preliminary evidence suggests it may also be effective against penile, anal, and vulvar cancers and even certain cancers of the head and neck.

«If this strategy is effective, then it might be broadly applicable not only against lung cancer but also against other cancers that express EGFR, which include brain, colon, and head and neck cancers,» said Dr. Gerber, Associate Professor of Internal Medicine and Clinical Sciences.

Cancer in the thyroid, which is located just below the «Adam's apple» area of the neck, is the fifth most common cancer diagnosed in Cancer in the thyroid, which is located just below the «Adam's apple» area of the neck, is the fifth most common cancer diagnosed in cancer diagnosed in women.

The authors report that higher levels of physical activity compared to lower levels were associated with lower risks of 13 of 26 cancers: esophageal adenocarcinoma (42 percent lower risk); liver (27 percent lower risk); lung (26 percent lower risk); kidney (23 percent lower risk); gastric cardia (22 percent lower risk); endometrial (21 percent lower risk); myeloid leukemia (20 percent lower risk); myeloma (17 percent lower risk); colon (16 percent lower risk); head and neck (15 percent lower risk), rectal (13 percent lower risk); bladder (13 percent lower risk); and breast (10 percent lower risk).

Finally, a Calgary, Alberta — based company, Oncolytics Biotech, is testing a reovirus (an RNA virus often found in human lungs but thought to be nonpathogenic) against several types of cancer, including that of the lung and skin as well as head and neck malignancies.

The group is launching a phase III trial of the engineered virus, called OncoVex, for head and neck cancer.

Heeke says the study would be open to people whose tumors have evidence of HRD like those found in this study, which includes bladder, breast, cervix, liver and bile duct, colorectal, endometrial, gastric / esophageal, head & neck, kidney, neuroendocrine, lung, ovarian, pancreas, prostate, sarcoma, and thyroid cancers, as well as gastrointestinal stromal tumors, glioma, melanoma and unknown primary cancers.

«Targeted drugs that are designed to inhibit any or all of these three steps might greatly improve the treatment of head and neck cancer.»

The findings provide information essential for designing novel targeted drugs that might improve the treatment of head and neck cancer.

«Nanog protein promotes growth of head and neck cancer.»

In 2011 the National Toxicology Program at the Department of Health and Human Services declared formaldehyde a known human carcinogen, demonstrated by human and animal studies to cause cancer of the nose, head, neck and lymphatic system.

«This study defines a signaling axis that is essential for head and neck cancer progression, and our findings show that this axis may be disrupted at three key steps,» says principal investigator Quintin Pan, PhD, associate professor of otolaryngology at the OSUCCC — James.

Researchers at Oregon State University are pursuing a new concept in treatment of epithelial cancer, especially head and neck cancer, by using two promising «analogs» of an old compound that was once studied as a potent anti-tumor agent, but long ago abandoned because it was too toxic.

• Speech language pathologists work with many types of patients including those who have cochlear implantation surgery, suffer from a voice disorder or during rehabilitation following treatment for head and neck cancer.

The effects of the pactamycin analogs, called TM - 025 and TM - 026, were characterized in head and neck cancer cell lines, which cause the eighth most common cancer in the world.

And although the vaccine has not been proven to prevent head and neck cancers, which can also be caused by HPV, the recent rise in cases of these cancers likely factored into the panel's reasoning for the recommendation, Schaffner said.

Low saliva production also is a devastating problem for thousands of patients who have had radiation treatment for head and neck cancer, as well as about 50 percent of older Americans whose medications can cause dry mouth, also known as xerostomia.

Silent Stories explores the strength of cancer patients who underwent radiotherapy to treat head or neck cancer.

Men who had smoked were nearly twice as likely to die from cancer, especially lung cancer, but there was also an elevated risk of death from cancers of the head and neck, esophagus, stomach, colorectum, liver, pancreas and bladder — all diseases that have been linked to smoking in previous studies, according to the authors.

Long associated with liver cancer and non-Hodgkin's lymphoma, a study from The University of Texas MD Anderson Cancer Center reveals for the first time that the hepatitis C virus (HCV) is associated with certain head and neck cacancer and non-Hodgkin's lymphoma, a study from The University of Texas MD Anderson Cancer Center reveals for the first time that the hepatitis C virus (HCV) is associated with certain head and neck caCancer Center reveals for the first time that the hepatitis C virus (HCV) is associated with certain head and neck cancers.

Specifically, data from the Cancer Genome Atlas showed signatures of APOBEC3 - mediated mutations in the PIK3CA gene of about 40 percent of HPV - positive head and neck cancers, but only about 10 percent of HPV - negative head and neck cancers.

Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic mutations needed to enable the immune system to recognize and attack malignant cells.

To investigate why checkpoint inhibitors so often stop working, Velculescu; Valsamo Anagnostou, M.D., Ph.D., instructor of oncology at the Johns Hopkins University School of Medicine; Kellie N. Smith, Ph.D., a cancer immunology research associate at the Johns Hopkins University School of Medicine; and their colleagues at the Bloomberg ~ Kimmel Institute for Cancer Immunotherapy studied tumors of four patients with non-small cell lung cancer and one patient with head and neck cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-cancer immunology research associate at the Johns Hopkins University School of Medicine; and their colleagues at the Bloomberg ~ Kimmel Institute for Cancer Immunotherapy studied tumors of four patients with non-small cell lung cancer and one patient with head and neck cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-Cancer Immunotherapy studied tumors of four patients with non-small cell lung cancer and one patient with head and neck cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-cancer and one patient with head and neck cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-CTLA4.

Other recent studies have recognized HCV's increased association with additional cancers, says Torres, but there was no known association with a significant number of head and neck cancers.

«To our surprise, we saw a number of head and neck cancer patients who tested positive for the hepatitis C virus.

Having only people with head and neck cancers in the study eliminates the variability of a group suffering from different forms of the disease, but it also eliminates information about whether patients with other forms of cancer would show the same results.

The results of the mouse, human and lab studies have been so successful that Dr. Bauman has started a larger clinical trial in volunteers previously cured of head and neck cancer.

Prior research has found that almost all head and neck cancer cells display an over-abundance of the protein, and it had been suggested in the literature as a potential target.

Dr. Bauman also collaborated with senior author Daniel E. Johnson, Ph.D., professor of medicine at Pitt and a senior scientist in the UPCI Head and Neck Cancer Program, to see how the extract performed in mice predisposed to head and neck cCancer Program, to see how the extract performed in mice predisposed to head and neck cancercancer.

«People who are cured of head and neck cancer are still at very high risk for a second cancer in their mouth or throat, and, unfortunately, these second cancers are commonly fatal,» said lead author Julie Bauman, M.D., M.P.H., co-director of the UPMC Head and Neck Cancer Center of Excelcancer are still at very high risk for a second cancer in their mouth or throat, and, unfortunately, these second cancers are commonly fatal,» said lead author Julie Bauman, M.D., M.P.H., co-director of the UPMC Head and Neck Cancer Center of Excelcancer in their mouth or throat, and, unfortunately, these second cancers are commonly fatal,» said lead author Julie Bauman, M.D., M.P.H., co-director of the UPMC Head and Neck Cancer Center of ExcelCancer Center of Excellence.

«With head and neck cancer, we often clear patients of cancer only to see it come back with deadly consequences a few years later,» said lead author Julie Bauman, M.D., M.P.H., co-director of the UPMC Head and Neck Cancer Center of Excelcancer, we often clear patients of cancer only to see it come back with deadly consequences a few years later,» said lead author Julie Bauman, M.D., M.P.H., co-director of the UPMC Head and Neck Cancer Center of Excelcancer only to see it come back with deadly consequences a few years later,» said lead author Julie Bauman, M.D., M.P.H., co-director of the UPMC Head and Neck Cancer Center of ExcelCancer Center of Excellence.

Dr. Bauman and her colleagues treated human head and neck cancer cells in the laboratory with varying doses of sulforaphane and a control, and compared them to normal, healthy cells that line the throat and mouth.

This research is funded through Pitt's Specialized Program of Research Excellence grant in head and neck cancer from the National Cancer Instcancer from the National Cancer InstCancer Institute.

According to the National Cancer Institute, at least 3 in 4 head and neck cancers are caused by the use of tobacco and alcohol.

This study, «Final Results of Local - Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer,» is a multi-institutional, randomized Phase III trial of fractionation in locally advanced head and neck cCancer,» is a multi-institutional, randomized Phase III trial of fractionation in locally advanced head and neck cancercancer.

«The decrease in the rate of new cancers was unexpected; however, the large database and the long follow - up provided us with a window into information that had not previously been available about the long - term patterns of head and neck tumors and is particularly heartening.

«This study, one of only a few large studies to have follow - up beyond five years, demonstrates that patients who have head and neck cancers and who are being treated with radiation therapy alone have improved local - regional control and no increase in late toxicity when radiation therapy is delivered twice a day in two smaller doses which we call hyperfractionation,» said Jonathan J. Beitler, MD, MBA, FASTRO, lead author of the study and professor of radiation oncology, otolaryngology and hematology / medical oncology at the Winship Cancer Institute of Emory University School of Medicine in Atlanta.